Login to Your Account



U.S. Patent Disclosures


Friday, December 16, 2011
• Ampio Pharmaceuticals Inc., of Greenwood Village, Colo., received notices for allowance for two patents. The first is directed to a class of compounds combining elements of diketopiperazines and methylphenidate derives, while the second is directed to derivatives of methylphenidate (Ritalin).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription